Matrixyl Morphomics
Cosmetic / Anti-AgingAlso known as: Palmitoyl Tripeptide-111
Cosmetic PeptidesResearch phase: Cosmetic ingredientRegulatory: Cosmetic ingredient. Not a drug. Not evaluated by FDA.
Mechanism
Matrixyl Morphomics is the newest generation of the Matrixyl peptide family, designed to remodel skin architecture by stimulating extracellular matrix components and improving skin morphology.
Technical detail
Matrixyl Morphomics (palmitoyl tripeptide-111) activates TGF-β signaling and extracellular matrix remodeling in the dermis. It promotes collagen, fibronectin, and hyaluronic acid synthesis while modulating MMP activity. Marketed as targeting the "skin morphome" for comprehensive age-related skin changes.